在印尼孕妇中使用人口特异性血液密度优化重量计方法解释:一项横截面研究
Nelil Mudarris1, Indrayani Indrayani2,3, Wisnu Arfian A Sudjarwo4
1Department of Midwifery, Universitas Bima Sakapenta, Bogor, Indonesia.
PloS one
|January 8, 2026
概括
这项研究测量了印尼孕妇的血液密度,发现它与人类的参考值保持一致. 这支持使用特定人群数据来提高产后出血 (PPH) 估计准确度.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇健康 孕产妇健康
- 临床化学 临床化学
背景情况:
- 准确的血液损失评估对于诊断产后出血 (PPH) 至关重要,但缺少一种黄金标准方法.
- 推用于低资源环境的重力测量方法来估计血液损失,但需要准确的血液密度值.
- 目前没有关于孕妇或分娩妇女血液密度的现有数据.
研究的目的:
- 为了测量印尼孕妇的血液密度.
- 为了提高重量计血损估计在产后出血 (PPH) 诊断中的可靠性.
主要方法:
- 对44名印尼孕妇 (怀孕≥37周) 进行了一项横截面研究.
- 在产前检查期间采集了5毫升静脉血液样本;高风险妊娠被排除在外.
- 描述性统计数据,斯皮尔曼的等级关系和克鲁斯卡尔-瓦利斯测试被用于分析.
主要成果:
- 平均血液密度为1.060±0.080g/ml (范围:0.860-1.194g/ml). 血液密度的平均值为1.060±0.080g/ml (范围:0.860-1.194g/ml). 血液密度的平均值为1.060±0.080g/ml. 血液密度的平均值为1.060±0.080g/ml. 血液密度的平均值为1.060±0.080g/ml.
- 血液密度与母亲年龄,BMI或妊娠期间体重增加之间没有发现显著的相关性.
- 克鲁斯卡尔-瓦利斯测试显示,在这些人口学变量中,血液密度没有显著差异.
结论:
- 印度尼西亚孕妇的血液密度与已确定的人类参考值保持一致.
- 使用特定人群血密度值可以提高PPH重量计血损失估计的准确性.
- 需要进一步的研究来探索其他影响血液密度变化的因素.
相关概念视频
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Gravimetry: Overview
12.9K
Gravimetric analysis is a quantitative method where the analyte is isolated and weighed directly or after conversion into a substance of known composition. Gravimetric analysis can be classified as precipitation, electrogravimetry, volatilization, and particulate gravimetry, based on the method used to isolate the analyte.
In precipitation gravimetry, the analyte is converted into a precipitate and weighed. For example, the silver content in a sample can be estimated by precipitating and...
In precipitation gravimetry, the analyte is converted into a precipitate and weighed. For example, the silver content in a sample can be estimated by precipitating and...
12.9K
Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Precipitation Gravimetry
13.8K
Precipitation gravimetry is based on converting an analyte into a sparingly soluble precipitate, which is separated by filtration and weighed. An ideal precipitate should be pure, insoluble, of known composition, and easily filtered from the reaction mixture.
In determining nickel by gravimetric analysis, a precipitant of ethanolic dimethylglyoxime is added to a hot nickel salt solution. This is quickly followed by the dropwise addition of dilute ammonia solution until precipitation occurs. A...
In determining nickel by gravimetric analysis, a precipitant of ethanolic dimethylglyoxime is added to a hot nickel salt solution. This is quickly followed by the dropwise addition of dilute ammonia solution until precipitation occurs. A...
13.8K
Analysis of Population Pharmacokinetic Data
671
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
671
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235


